Dr. Horizon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8640 W 3rd St
Ste 300
Los Angeles, CA 90048Phone+1 310-659-7878Fax+1 310-659-7117
Education & Training
Cedars-Sinai Medical CenterFellowship, Rheumatology, 2001 - 2003
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1998 - 2001
University of California San Diego School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2025
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Most Compassionate Doctor American Registry
- Super Doctor SuperDoctors.com
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsRisk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.Arash A Horizon, Daniel J. Wallace
Expert Opinion on Drug Safety. 2004-07-01 - 12 citationsThe T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders.Dalin Li, Alexander Xu, Emebet Mengesha, Rebecca Elyanow, Rachel M Gittelman
Medrxiv. 2021-12-08 - 20 citationsThe T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy.Dalin Li, Alexander Xu, Emebet Mengesha, Rebecca Elyanow, Rachel M Gittelman
Inflammatory Bowel Diseases. 2022-07-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
